JENNIFER L. GOOD - President & CEO, Director at Trevi Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
TRVI on Nasdaq
All Insider Reports
All Insider Reports

JENNIFER L. GOOD - trading volume in the past year for Trevi Therapeutics, Inc.

Holdings reported by JENNIFER L. GOOD for Trevi Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 213,313 $1,403,365 $6.58 21 Mar 2025 Direct
Stock Option (right to buy) 675,000 19 Feb 2026 Direct Common Stock
Performance Stock Option (right to buy) 156,400 31 May 2025 Direct Common Stock

Transactions reported by JENNIFER L. GOOD for Trevi Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.